Antisense Growth Inhibition of Ewing’s Sarcoma and Related Tumor Cells
نویسندگان
چکیده
The translocation t(11;22) is a common chromosomal abnormality detected both in Ewing’s sarcoma and in primitive neuroectodermal tumor cells. The translocation results in an EWS-Fli1 fusion gene, made up of the 5 9 half of the EWS gene on chromosome 22 fused to the 3 9 half of the Fli1 gene on chromosome 11. Recent studies have evaluated possible roles of the fusion gene products. However, the biological significance of EWS-Fli1 is still unknown. Using a competitive polymerase chain reaction technique, we show here that there might be a correlation between the expression levels of the EWS-Fli1 fusion gene and the proliferative activities of Ewing’s sarcoma and primitive neuroectodermal tumor cells. When the EWS-Fli1 expression is inhibited by antisense oligodeoxynucleotides against the fusion RNA, the growth of the tumor cells is significantly reduced both in vitro and in vivo. The data further indicate the growth inhibition of the cells by the antisense sequence might be mediated by G 0 /G 1 block in the cell cycle progression. These results suggest that EWS-Fli1 may play an important role in the proliferation of the tumor cells, and the EWS-Fli1 fusion RNA could be used as a target to inhibit the growth of Ewing’s sarcoma and primitive neuroectodermal tumor with the specific antisense oligonucleotide. ( J. Clin. Invest. 1997. 99:239–247.)
منابع مشابه
ANTISENSE RNA TO THE TYPE I INSULIN-LIKE GROWTH FACTOR RECEPTOR REVERSED THE TRANSFORMED PHENOTYPE OF PC-3 HUMAN PROSTATE CANCER CELL LINE IN VITRO
The insulin-like growth factor I receptor (IGF-IR) plays an essential role in the establishment and maintenance of transformed phenotype. Interference with the IGF-IR pathway by antisense causes reversal of the transformed phenotype in many rodent and human tumor cell lines. We stably transfected the PC-3 human prostate cancer cell line with an IGF-IR antisense RNA expression plasmid. The ...
متن کاملTaking aim at Ewing's sarcoma: is KIT a target and will imatinib work?
Ewing’s sarcoma is the second most common primary bone tumor in children. Although the cure rate for localized disease is approximately 50%, it requires intensive multiagent chemotherapy, surgery, and radiation therapy. Patients with metastatic, recurrent, or refractory disease have a much poorer prognosis. In this issue of the Journal, Merchant et al. (1) evaluate the sensitivity of Ewing’s sa...
متن کاملFNAC of Extra-Skeletal Ewing’s Sarcoma of the Parotid Gland
Extra-skeletal Ewing’s sarcoma is a rare soft tissue malignant neoplasm, morphologically indistinguishable from skeletal Ewing’s sarcoma. The usual sites of involvement are the soft tissues of para-vertebral region, chest wall, and lower extremity. Extra-skeletal Ewing’s sarcoma is rare in the head and neck region and very few cases are reported in the parotid gland. The cytological features...
متن کاملClinicopathologic characteristics and outcome of childhood and adolescent Ewing’s sarcoma in center of Iran
Background Ewing’s sarcoma family is a group of small round cells tumors. The aim of this study is to evaluate clinicopathologic characteristics and outcome of Ewing’s sarcoma in children and adolescents in Yazd, Iran. Materials and Methods All patients under 19 years with documented pathology of Ewing’s sarcoma family tumor who referred to Shahid Ramazanzadeh Radiotherapy center between 2...
متن کاملExtraskeletal Ewing’s Sarcoma of Neck in a Child- A Case Report
Introduction: Ewing's sarcoma (ES) is an extremely rare bone malignancy observed in otorhinolaryngeal practice. In otorhinolaryngology, it sometimes involves the facial bones and cervical vertebrae. In children, ES is the second most common primary malignancy of bone after osteosarcoma. Extraskeletal Ewing’s sarcoma (EES) is an extremely rare malignancy of mesenchymal cell origin. The EES...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2013